0001209191-16-090832.txt : 20160111
0001209191-16-090832.hdr.sgml : 20160111
20160111203555
ACCESSION NUMBER: 0001209191-16-090832
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160111
FILED AS OF DATE: 20160111
DATE AS OF CHANGE: 20160111
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ADURO BIOTECH, INC.
CENTRAL INDEX KEY: 0001435049
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 626 BANCROFT WAY
STREET 2: SUITE 3-C
CITY: BERKELEY
STATE: CA
ZIP: 94710
BUSINESS PHONE: 510-848-4400
MAIL ADDRESS:
STREET 1: 626 BANCROFT WAY
STREET 2: SUITE 3-C
CITY: BERKELEY
STATE: CA
ZIP: 94710
FORMER COMPANY:
FORMER CONFORMED NAME: ADURO BIOTECH
DATE OF NAME CHANGE: 20080514
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brockstedt Dirk G.
CENTRAL INDEX KEY: 0001635616
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37345
FILM NUMBER: 161337510
MAIL ADDRESS:
STREET 1: C/O ADURO BIOTECH, INC.
STREET 2: 626 BANCROFT WAY, 3C
CITY: BERKELEY
STATE: CA
ZIP: 94710
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-01-11
0
0001435049
ADURO BIOTECH, INC.
ADRO
0001635616
Brockstedt Dirk G.
C/O ADURO BIOTECH, INC.
626 BANCROFT WAY, 3C
BERKELEY
CA
94710
0
1
0
0
Sr. VP of Research and Dev.
Common Stock
2016-01-11
4
M
0
956
1.45
A
12956
D
Common Stock
2016-01-11
4
S
0
956
23.51
D
12000
D
Common Stock
2016-01-11
4
M
0
21044
0.45
A
33044
D
Common Stock
2016-01-11
4
S
0
18638
21.57
D
14406
D
Common Stock
2016-01-11
4
S
0
1706
22.40
D
12700
D
Common Stock
2016-01-11
4
S
0
700
23.29
D
12000
D
Stock Option (Right to Buy)
1.45
2016-01-11
4
M
0
956
0.00
D
2025-01-09
Common Stock
956
290106
D
Stock Option (Right to Buy)
0.45
2016-01-11
4
M
0
21044
0.00
D
2020-03-18
Common Stock
21044
51195
D
The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2015.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $22.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.01 to $23.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.10 to $23.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The shares subject to the Option vest in 48 equal monthly installments from the vesting commencement date of January 10, 2015.
The shares subject to the Option are fully vested and immediately exercisable.
/s/ Jennifer Lew, Attorney-in-Fact
2016-01-11